Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – What’s Next?

Shares of Hypermarcas (OTCMKTS:HYPMY) gapped up before the market opened on Tuesday . The stock had previously closed at $3.81, but opened at $4.0510. Hypermarcas shares last traded at $4.0510, with a volume of 8,913 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy”.

Hypermarcas Price Performance

The company has a 50 day simple moving average of $4.44 and a 200 day simple moving average of $4.42. The company has a market capitalization of $2.76 billion, a price-to-earnings ratio of 8.17 and a beta of 0.70. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $383.13 million for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. As a group, research analysts predict that Hypermarcas will post 0.53 EPS for the current year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.